Tanja Holopainen

2.7k total citations
27 papers, 2.1k citations indexed

About

Tanja Holopainen is a scholar working on Molecular Biology, Oncology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Tanja Holopainen has authored 27 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 17 papers in Oncology and 4 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Tanja Holopainen's work include Angiogenesis and VEGF in Cancer (17 papers), Lymphatic System and Diseases (13 papers) and Vascular Tumors and Angiosarcomas (6 papers). Tanja Holopainen is often cited by papers focused on Angiogenesis and VEGF in Cancer (17 papers), Lymphatic System and Diseases (13 papers) and Vascular Tumors and Angiosarcomas (6 papers). Tanja Holopainen collaborates with scholars based in Finland, United States and South Korea. Tanja Holopainen's co-authors include Kari Alitalo, Seppo Ylä‐Herttuala, Michael Jeltsch, Tuomas Tammela, Andrey Anisimov, Anne Saaristo, Takashi Takahashi, Denis Tvorogov, Yulong He and Tatiana V. Petrova and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Circulation and Journal of Clinical Investigation.

In The Last Decade

Tanja Holopainen

27 papers receiving 2.1k citations

Peers

Countries citing papers authored by Tanja Holopainen

Since Specialization

Citations

This map shows the geographic impact of Tanja Holopainen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tanja Holopainen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tanja Holopainen more than expected).

Fields of papers citing papers by Tanja Holopainen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tanja Holopainen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tanja Holopainen. The network helps show where Tanja Holopainen may publish in the future.

Co-authorship network of co-authors of Tanja Holopainen

This figure shows the co-authorship network connecting the top 25 collaborators of Tanja Holopainen. A scholar is included among the top collaborators of Tanja Holopainen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tanja Holopainen. Tanja Holopainen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Treating cachexia using soluble ACVR2B improves survival, alters mTOR localization, and attenuates liver and spleen responses 2018 ·Journal of Cachexia Sarcopenia and Muscle ·Tuuli A. Nissinen, (unknown), Fabio Penna, A. Lampinen, (unknown), (unknown), Tanja Holopainen, Olli Ritvos, Riikka Kivelä, Juha J. Hulmi	47
2	Elevated VEGF-D Modulates Tumor Inflammation and Reduces the Growth of Carcinogen-Induced Skin Tumors 2016 ·Neoplasia ·(unknown), Valerio Izzi, (unknown), Tanja Holopainen, (unknown), Taina Pihlajaniemi, Kari Alitalo, Ritva Heljäsvaara	12
3	MMP16 Mediates a Proteolytic Switch to Promote Cell–Cell Adhesion, Collagen Alignment, and Lymphatic Invasion in Melanoma 2015 ·Cancer Research ·Olga Tatti, Erika Gucciardo, Pirita Pekkonen, Tanja Holopainen, Riku Louhimo, Pauliina Repo, Pilvi Maliniemi, Jouko Lohi, Ville Rantanen, Sampsa Hautaniemi, Kari Alitalo, Annamari Ranki, Päivi M. Ojala, Jorma Keski‐Oja, Kaisa Lehti	58
4	Assessment of tumour viability in human lung cancer xenografts with texture-based image analysis 2015 ·Journal of Clinical Pathology ·Riku Turkki, Nina Linder, Tanja Holopainen, Yinhai Wang, Anne Grote, Mikael Lundin, Kari Alitalo, Johan Lundin	14
5	CCBE1 Enhances Lymphangiogenesis via A Disintegrin and Metalloprotease With Thrombospondin Motifs-3–Mediated Vascular Endothelial Growth Factor-C Activation 2014 ·Circulation ·Michael Jeltsch, Sawan Kumar Jha, Denis Tvorogov, Andrey Anisimov, Veli‐Matti Leppänen, Tanja Holopainen, Riikka Kivelä, Sagrario Ortega, Terhi Kärpänen, Kari Alitalo	178
6	Angiopoietin 2 regulates the transformation and integrity of lymphatic endothelial cell junctions 2014 ·Genes & Development ·Wei Zheng, Harri Nurmi, Sila Appak‐Baskoy, Amélie Sabine, Esther Bovay, Emilia A. Korhonen, Fabrizio Orsenigo, Marja Lohela, Gabriela D’Amico, Tanja Holopainen, Ching Ching Leow, Elisabetta Dejana, Tatiana V. Petrova, Hellmut G. Augustin, Kari Alitalo	97
7	Prox1 Promotes Expansion of the Colorectal Cancer Stem Cell Population to Fuel Tumor Growth and Ischemia Resistance 2014 ·Cell Reports ·Zoltán Wiener, (unknown), (unknown), Arja M. Band, Pauliina Kallio, Tanja Holopainen, Olli Dufva, Caj Haglund, Olli Kruuna, Guillermo Oliver, Yinon Ben‐Neriah, Kari Alitalo	61
8	Tie1 deletion inhibits tumor growth and improves angiopoietin antagonist therapy 2014 ·Journal of Clinical Investigation ·Gabriela D’Amico, Emilia A. Korhonen, Andrey Anisimov, Georgia Zarkada, Tanja Holopainen, René Hägerling, Friedemann Kiefer, Lauri Eklund, Raija Sormunen, Harri Elamaa, Rolf A. Brekken, Ralf H. Adams, Gou Young Koh, Pipsa Saharinen, Kari Alitalo	65
9	Vascular Endothelial Growth Factor-Angiopoietin Chimera With Improved Properties for Therapeutic Angiogenesis 2013 ·Circulation ·Andrey Anisimov, Denis Tvorogov, Annamari Alitalo, Veli‐Matti Leppänen, (unknown), Eun Chun Han, Fabrizio Orsenigo, Emília Ilona Gaál, Tanja Holopainen, Young Jun Koh, Tuomas Tammela, Petra Korpisalo, Salla Keskitalo, Michael Jeltsch, Seppo Ylä‐Herttuala, Elisabetta Dejana, Gou Young Koh, Chulhee Choi, Pipsa Saharinen, Kari Alitalo	48
10	The Basis for the Distinct Biological Activities of Vascular Endothelial Growth Factor Receptor–1 Ligands 2013 ·Science Signaling ·Andrey Anisimov, Veli‐Matti Leppänen, Denis Tvorogov, Georgia Zarkada, Michael Jeltsch, Tanja Holopainen, Seppo Kaijalainen, Kari Alitalo	46
11	Deletion of the Endothelial Bmx Tyrosine Kinase Decreases Tumor Angiogenesis and Growth 2012 ·Cancer Research ·Tanja Holopainen, (unknown), Wei Zheng, Ritva Heljäsvaara, Dennis Jones, Yun He, Denis Tvorogov, Gabriela D’Amico, Zoltán Wiener, Leif C. Andersson, Taina Pihlajaniemi, Min Wang, Kari Alitalo	27
12	Effects of Angiopoietin-2-Blocking Antibody on Endothelial Cell–Cell Junctions and Lung Metastasis 2012 ·JNCI Journal of the National Cancer Institute ·Tanja Holopainen, Pipsa Saharinen, Gabriela D’Amico, (unknown), Lauri Eklund, Raija Sormunen, Andrey Anisimov, Georgia Zarkada, Marja Lohela, Hanna Heloterä, Tuomas Tammela, Laura E. Benjamin, Seppo Ylä‐Herttuala, Ching Ching Leow, Gou Young Koh, Kari Alitalo	6
13	Perspectives on lymphangiogenesis and angiogenesis in cancer 2011 ·Journal of Surgical Oncology ·Tanja Holopainen, Maija Bry, Kari Alitalo, Anne Saaristo	35
14	Effective Suppression of Vascular Network Formation by Combination of Antibodies Blocking VEGFR Ligand Binding and Receptor Dimerization 2010 ·Cancer Cell ·Denis Tvorogov, Andrey Anisimov, Wei Zheng, Veli‐Matti Leppänen, Tuomas Tammela, Simonas Laurinavičius, Wolfgang Holnthoner, Hanna Heloterä, Tanja Holopainen, Michael Jeltsch, Nisse Kalkkinen, Hilkka Lankinen, Päivi M. Ojala, Kari Alitalo	99
15	Angiopoietin-1 Overexpression Modulates Vascular Endothelium to Facilitate Tumor Cell Dissemination and Metastasis Establishment 2009 ·Cancer Research ·Tanja Holopainen, Huilian Huang, Caiping Chen, Kyung Eun Kim, Luqing Zhang, Fei Zhou, Wencan Han, Chaojun Li, Jun Yu, Jun Wu, Gou Young Koh, Kari Alitalo, Yulong He	44
16	The Tyrosine Kinase Inhibitor Cediranib Blocks Ligand-Induced Vascular Endothelial Growth Factor Receptor-3 Activity and Lymphangiogenesis 2008 ·Cancer Research ·Caroline A. Heckman, Tanja Holopainen, Maria Wirzenius, Salla Keskitalo, Michael Jeltsch, Seppo Ylä‐Herttuala, Stephen R. Wedge, Juliane M. Jürgensmeier, Kari Alitalo	95
17	Vascular Endothelial Growth Factor Receptor 3 Is Involved in Tumor Angiogenesis and Growth 2007 ·Cancer Research ·Pirjo Laakkonen, Marika Waltari, Tanja Holopainen, Takashi Takahashi, Bronislaw Pytowski, Philipp Steiner, Daniel J. Hicklin, Kris Persaud, James R. Tonra, Larry Witte, Kari Alitalo	184
18	Inhibition of VEGF-C-induced VEGFR-3 activity and lymphatic endothelial cell function by the tyrosine kinase inhibitor AZD2171 2007 ·Cancer Research ·Caroline A. Heckman, Tanja Holopainen, Maria Wirzenius, Salla Keskitalo, Michael Jeltsch, Stephen R. Wedge, Juliane M. Jürgensmeier	1
19	Therapeutic differentiation and maturation of lymphatic vessels after lymph node dissection and transplantation 2007 ·Nature Medicine ·Tuomas Tammela, Anne Saaristo, Tanja Holopainen, (unknown), Anna Kotronen, Miia Pitkonen, Usama Abo‐Ramadan, Seppo Ylä‐Herttuala, Tatiana V. Petrova, Kari Alitalo	290
20	Technique and Practical Problems: Suitability of Isotope Renography for Study of the Kidney in Pregnancy 1965 ·Scandinavian Journal of Clinical and Laboratory Investigation ·(unknown), A. Rekonen, Tanja Holopainen	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact